France widens COVID vaccine rollout to 16-17 year olds at high risk of major illness By Reuters

May 6, 2021 admin Stock News 0

© Reuters. FILE PHOTO: People wait to be given a COVID-19 vaccine in Nice, France, April 29, 2021. REUTERS/Eric Gaillard

PARIS (Reuters) – France has decided to widen its COVID-19 vaccine rollout to people aged 16-17 who could face a high risk of a major illness from the virus, said the country’s health ministry on Thursday, as the country gradually accelerates its vaccine programme.

The health ministry said this category of 16-17 year olds would be allowed to get the Pfizer/BioNTech COVID vaccine from Thursday onwards.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*